These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Rebalanced hemostasis in liver disease: a misunderstood coagulopathy. Roberts LN Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):485-491. PubMed ID: 34889414 [TBL] [Abstract][Full Text] [Related]
23. [The mechanisms of disorders in the hemostatic system of patients with chronic diffuse liver diseases]. Podymova SD; Serov NA; Serov VA; Sukhanov VA; Brodskaia IK Ter Arkh; 1990; 62(2):72-6. PubMed ID: 2336628 [TBL] [Abstract][Full Text] [Related]
24. The coagulopathy of chronic liver disease: is there a causal relationship with bleeding? Yes. Basili S; Raparelli V; Violi F Eur J Intern Med; 2010 Apr; 21(2):62-4. PubMed ID: 20206871 [TBL] [Abstract][Full Text] [Related]
25. Hematologic manifestations of liver disease. Marks PW Semin Hematol; 2013 Jul; 50(3):216-21. PubMed ID: 23953338 [TBL] [Abstract][Full Text] [Related]
26. [Liver cirrhosis and coagulopathy]. Scharrer I Hamostaseologie; 2005 May; 25(2):205-8. PubMed ID: 15924159 [TBL] [Abstract][Full Text] [Related]
30. Coagulation abnormalities in liver disease. Mammen EF Hematol Oncol Clin North Am; 1992 Dec; 6(6):1247-57. PubMed ID: 1333467 [TBL] [Abstract][Full Text] [Related]
31. [Fibrinolysis as a cause of coagulopathy in patients with chronic diffuse diseases of the liver]. Serov NA; Sukhanov VA; Podymova SD Klin Med (Mosk); 1991 Apr; 69(4):73-5. PubMed ID: 1865658 [TBL] [Abstract][Full Text] [Related]
32. [Diagnostic clarification of coagulopathies]. Beck EA Schweiz Med Wochenschr; 1971 Nov; 101(46):1653-7. PubMed ID: 5140631 [No Abstract] [Full Text] [Related]
33. [Intravascular blood microcoagulation in liver diseases]. Svintsitskiĭ AS; Ena IaM; Andreev AP; Futornyĭ SM Lik Sprava; 1996; (7-9):8-12. PubMed ID: 9072275 [No Abstract] [Full Text] [Related]
34. [Hemostatic disorders in liver cirrhosis (in relation to the extent of portal hypertension)]. Liehr H; Hörder MH; Mersch-Baumert K Acta Hepatosplenol; 1971; 18(3):166-71. PubMed ID: 5089183 [No Abstract] [Full Text] [Related]
35. [Coagulation changes in liver diseases. Synthesis defects and disseminated intravascular coagulation]. Escribá A; Maluenda MP; Del Potro E; Peñalver MA; Espinós D Sangre (Barc); 1982; 27(4-B):680-704. PubMed ID: 6760429 [No Abstract] [Full Text] [Related]
36. Diagnosis and therapy of coagulopathies in patients with liver disease. Corrigan JJ Contemp Anesth Pract; 1981; 4():1-11. PubMed ID: 7226837 [TBL] [Abstract][Full Text] [Related]
37. [Clinical use of a test for determination of coagulation factors II, X and VII]. Cascino A; Cangiano C; Attili AF Minerva Med; 1975 Aug; 66(55):2743-9. PubMed ID: 1161171 [TBL] [Abstract][Full Text] [Related]
38. Endogenous heparinoids contribute to coagulopathy in patients with liver disease. Senzolo M; Riddell A; Tuddenham E; Burroughs AK J Hepatol; 2008 Feb; 48(2):371-2; author reply 372-3. PubMed ID: 18093682 [No Abstract] [Full Text] [Related]
39. [The liver and hemostasis]. Maragall Marfá S Med Clin (Barc); 1984 Feb; 82(7):311-3. PubMed ID: 6717136 [No Abstract] [Full Text] [Related]
40. Blood component therapy for abnormalities of hemostasis in liver disease. Glassman AB Conn Med; 1972 Oct; 36(10):572-5. PubMed ID: 5086117 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]